Table 3.
The relationship between miR-589-5p expression and clinic parameters in human HCC (n = 40)
| Parameters | miR-589-5pLow | miR-589-5pHigh | p Value | |
|---|---|---|---|---|
| Male/Female | 15/4 | 20/1 | 0.281 | |
| Age* | 50 (32-65) | 48 (32-61) | 0.849 | |
| HBsAg | ||||
| Positive | 15 (78.9 %) | 20 (95.2 %) | 0.281 | |
| Negative | 4 (21.1) | 1 (4.8 %) | ||
| AFP | ||||
| Normal | 9 (47.4 %) | 12 (57.1 %) | 0.536 | |
| High | 10 (52.6 %) | 9 (42.9 %) | ||
| Vascular Invasion | ||||
| Positive | 7 (36.8 %) | 1 (4.8 %) | 0.033 | |
| Negative | 12 (63.2 %) | 20 (95.2 %) | ||
| Tumer Size(cm)* | 7 (4-16) | 5.5 (2.5-15) | 0.254 | |
| Recurrence | 18 (94.7 %) | 10 (47.6 %) | 0.001 | |
| Edmondson Grade | I/II | 10 (52.6 %) | 17 (81.0 %) | 0.056 |
| III/IV | 9 (47.4 %) | 4 (19.0 %) | ||
*Value expressed in the midian with the range in parentheses